Janux Therapeutics, Inc. Common Stock JANX
$12.76
-27.62%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (10 Buy · 2 Hold · 1 Sell)
- Average Price Target
- $36.38
- Implied Upside
- +185.1%
- Price Target Range
- $12.00 – $100.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-06 | Truist SecuritiesSupawat Thongthip |
Maintains | Buy | $26 → $27 |
| 2026-11-06 | WedbushRobert Driscoll |
Maintains | Outperform | $36 → $40 |
| 2026-11-06 | BarclaysEtzer Darout |
Maintains | Underweight | $14 → $15 |
| 2026-08-24 | Wolfe ResearchKalpit Patel |
Upgrades | Peer perform → Outperform | $23 |
| 2026-08-07 | GuggenheimBrad Canino |
Maintains | Buy | $58 → $55 |
| 2026-06-25 | Truist SecuritiesSupawat Thongthip |
Assumes | Buy | $80 → $26 |
| 2026-05-08 | Piper SandlerKelsey Goodwin |
Maintains | Overweight | $30 → $26 |
| 2026-05-08 | WedbushRobert Driscoll |
Maintains | Outperform | $45 → $36 |
| 2026-05-08 | GuggenheimBrad Canino |
Maintains | Buy | $68 → $58 |
| 2026-04-28 | Jones TradingBoris Peaker |
Maintains | Buy | $50 → $28 |
| 2026-04-20 | BarclaysEtzer Darout |
Downgrades | Overweight → Underweight | $29 → $14 |
| 2026-04-15 | UBSDavid Dai |
Downgrades | Buy → Neutral | $57 → $15 |
| 2026-02-27 | Cantor FitzgeraldJosh Schimmer |
Maintains | Overweight | $150 → $100 |
| 2026-02-27 | GuggenheimBrad Canino |
Maintains | Buy | $72 → $68 |
| 2026-01-20 | Clear StreetKaveri Pohlman |
Downgrades | Buy → Hold | $32 → $12 |
| 2026-01-16 | Piper SandlerKelsey Goodwin |
Maintains | Overweight | $42 → $30 |
| 2025-12-17 | BarclaysEtzer Darout |
Maintains | Overweight | $48 → $29 |
| 2025-12-02 | StifelBradley Canino |
Maintains | Buy | $46 → $38 |
| 2025-12-02 | Clear StreetKaveri Pohlman |
Maintains | Buy | $80 → $32 |
| 2025-12-02 | B of A SecuritiesGeoff Meacham |
Maintains | Buy | $58 → $49 |
| 2025-12-02 | Cantor FitzgeraldJosh Schimmer |
Maintains | Overweight | $200 → $150 |
| 2025-12-02 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $70 → $45 |
| 2025-11-25 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $70 |
| 2025-11-18 | Wolfe ResearchKalpit Patel |
Initiates coverage on | Peer perform | — |
| 2025-11-07 | BarclaysEtzer Darout |
Maintains | Overweight | $47 → $48 |
| 2025-09-17 | BarclaysEtzer Darout |
Initiates coverage on | Overweight | $47 |
| 2025-09-10 | Truist SecuritiesAsthika Goonewardene |
Initiates coverage on | Buy | $100 |
| 2025-09-10 | StifelBradley Canino |
Reinstates | Buy | $45 |
| 2025-09-04 | GuggenheimBrad Canino |
Initiates coverage on | Buy | $72 |
| 2025-08-19 | Piper SandlerKelsey Goodwin |
Initiates coverage on | Overweight | $42 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $12.76
- Market Cap
- $1.08 billion
- 52-Week Range
- $12.12 – $35.34
- Average Volume
- 907K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.